Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-102008

ABSTRACT: Peripheral blood biomarkers in Friedreich's ataxia

DISEASE(S): Normal,Friedreich Ataxia

PROVIDER: E-GEOD-102008 | ExpressionAtlas | 2019-04-01

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-102008-analysis-methods.tsv	Tabular
	E-GEOD-102008-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-102008-configuration.xml	Xml
	E-GEOD-102008-percentile-ranks.tsv	Tabular
	E-GEOD-102008.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 61

Similar Datasets

Homo sapiens

Project description:Peripheral blood biomarkers in Friedreich's ataxia

| PRJNA396198 | ENA

A Gene Expression Phenotype In Lymphocytes From Friedreich’s Ataxia Patients

Project description:Gene expression studies in peripheral tissues from patients with neurodegenerative disorders can provide insights into disease pathogenesis, and identify potential biomarkers, an important goal of translational research in neurodegeneration. Friedreich’s Ataxia (FRDA) is a chronic neurodegenerative disease caused by reduced transcription of frataxin, a ubiquitously expressed protein. We studied in vitro lymphocytes from FRDA patients and carriers, in order to identify a peripheral gene expression phenotype. Peripheral biomarkers related to disease status would be extremely valuable for assessing drug efficacy and could provide new pathophysiological insights. We identified a subset of genes changed in cells from patients with pathological frataxin deficiency and a core set of these genes were confirmed in independent series. Changes in gene expression were related to the mitochondria, lipid metabolism, cell cycle, and DNA repair, consistent with FRDA’s known pathophysiology. We evaluated the in vitro effect of multiple compounds (HDAC inhibitors) on this putative biomarker set, and found that this biochemical phenotype was ameliorated in accordance with drug efficacy. Frataxin downregulation is associated with robust changes in gene expression in PBMCs, providing pathogenetic insights and a core subset of genes which, if verified in vivo, could be used as a peripheral biomarker. We characterized the gene expression profiles in peripheral blood mononuclear cells (PBMCs) from FRDA patients, compared with controls and related carriers. Cells were studied both before and after in vitro treatment with compounds that increase frataxin levels. Quantitative real-time PCR and additional microarrays were used to confirm a core set of genes in multiple independent series

2011-07-25 | E-GEOD-30933 | biostudies-arrayexpress

Integrated extracellular microRNA profiling for uterine sarcomas

Project description:MicroRNAs stably exist in the peripheral blood and can be potential biomarkers. In this study, we evaluated the serum miRNA profiles of patients with uterine sarcomas.

2023-06-15 | GSE235028 | GEO

Dopamine-regulated biomarkers in peripheral blood of HIV+ Methamphetamine users

Project description:Dopamine-regulated biomarkers in peripheral blood of HIV+ Methamphetamine users

| PRJNA1142530 | ENA

Peripheral Blood Monocyte Abundance Predicts Outcomes in Breast Cancer Patients

Project description:Biomarkers of response are needed in breast cancer to stratify patients to appropriate therapies and avoid unnecessary toxicity. Peripheral blood gene expression and cell type abundance were used to identify biomarkers of response and recurrence in neoadjuvant chemotherapy treated breast cancer patients. Higher peripheral blood monocyte abundance after neoadjuvant chemotherapy was associated with improved prognosis in multiple independent cohorts of breast cancer patients.

2022-04-26 | GSE201085 | GEO

Gene Expression Profiles Predict Postpartum-onset Depression Patients with Treatment-Resistant Depression Patients with Treatment-Resistant Depression

Project description:To identify early predictive biomarkers for postpartum depression using peripheral blood gene expression profiles

2013-03-29 | GSE45603 | GEO

Tracking the progression of Alzheimer’s disease with peripheral blood-based biomarkers

Project description:Tracking the progression of Alzheimer’s disease with peripheral blood-based biomarkers

| PRJNA896178 | ENA

Homo sapiens

Project description:The identification of miRNA biomarkers in CFS/ME peripheral blood samples

| PRJNA288455 | ENA

Rattus norvegicus

Project description:Analysis of potential transcriptomic biomarkers for doxorubicin cardiotoxicity in peripheral blood